Citation Impact
Citing Papers
An efficient and convenient Cu(OAc)2/air mediated oxidative coupling of azoles via C–H activation
2009
Structural Rearrangements in the Thyroid Hormone Receptor Hinge Domain and Their Putative Role in the Receptor Function
2006
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Energy balance regulation by thyroid hormones at central level
2013
Sobetirome: a case history of bench-to-clinic drug discovery and development
2008
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Current and Future Drug Targets in Weight Management
2010
Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist #
2008
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist
2013
Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets
2004
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association
2012
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
2009
Blind docking of pharmaceutically relevant compounds using RosettaLigand
2009 StandoutNobel
Potential therapeutic applications of thyroid hormone analogs
2007
Hydrogel nanoparticles in drug delivery
2008 Standout
Hydroxylated polybrominated diphenyl ethers exhibit different activities on thyroid hormone receptors depending on their degree of bromination
2013
Temperature-sensitive hydrogels with SiO2–Au nanoshells for controlled drug delivery
2007
Functional Brown Adipose Tissue in Healthy Adults
2009 Standout
Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia
2010
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Progress in research on gold nanoparticles in cancer management
2019 Standout
Treatment Targets in the Management of Dyslipidemias: Which Targets in Whom?
2012
Direct effects of thyroid hormones on hepatic lipid metabolism
2018
The golden age: gold nanoparticles for biomedicine
2011 Standout
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Copper-catalyzed ortho-acylation of phenols with aryl aldehydes and its application in one-step preparation of xanthones
2012
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
2010
New insights into thyroid hormone action
2007
Neurodevelopmental and Neurophysiological Actions of Thyroid Hormone
2008
Thyroid Hormone Analogues for the Treatment of Metabolic Disorders: New Potential for Unmet Clinical Needs?
2012
Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARα-dependent Manner
2010
Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes
2009
The hallmarks of cancer
2012 Standout
Thyroid hormones and the control of cell proliferation or cell differentiation: Paradox or duality?
2009
Gold nanorods and their plasmonic properties
2012 Standout
RosettaLigand Docking with Full Ligand and Receptor Flexibility
2008 StandoutNobel
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
2016 Standout
Protein-immobilized Electrode for Rapid and Convenient Sensing of Thyroid Hormone Receptor-ligand Interaction
2003
Nuclear Receptors Reverse McGarry's Vicious Cycle to Insulin Resistance
2012
Thyroxine-Thyroid Hormone Receptor Interactions
2004
Cellular bioenergetics as a target for obesity therapy
2010
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
Impact of Weight-Loss Medications on the Cardiovascular System
2007
Ghrelin: Structure and Function
2005 Standout
Expression of Uncoupling Protein 1 in Mouse Brown Adipose Tissue Is Thyroid Hormone Receptor-β Isoform Specific and Required for Adaptive Thermogenesis
2009
Retinoid X Receptor Heterodimers in the Metabolic Syndrome
2005
European Guidelines for Obesity Management in Adults
2015 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Thyroid hormone receptors: The challenge of elucidating isotype-specific functions and cell-specific response
2012
Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association
2012
Mechanisms of thyroid hormone action
2012
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Metabolic Effects of Thyroid Hormone Derivatives
2008
Thyroid Hormone and Adipocyte Differentiation
2008
Effects of Thyroid Hormone Analogs on Lipid Metabolism and Thermogenesis
2008
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Thyroid-Disrupting Chemicals: Interpreting Upstream Biomarkers of Adverse Outcomes
2009
3d Transition Metals for C–H Activation
2018 Standout
Role of Halogen Bonds in Thyroid Hormone Receptor Selectivity: Pharmacophore-Based 3D-QSSR Studies
2009
Bond Formations between Two Nucleophiles: Transition Metal Catalyzed Oxidative Cross-Coupling Reactions
2011 Standout
Cross‐Coupling Reactions on Azoles with Two and More Heteroatoms
2006
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Thyroid Hormone-Related Regulation of Gene Expression in Human Fatty Liver
2009
Oxidative Coupling between Two Hydrocarbons: An Update of Recent C–H Functionalizations
2015 Standout
Mild metal-catalyzed C–H activation: examples and concepts
2016 Standout
Palladium-Catalyzed, Ligand-Free Suzuki Reaction in Water Using Aryl Fluorosulfates
2015 StandoutNobel
Rational Design of Potent and Selective Inhibitors of an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa
2016
Transition metals in organic synthesis: Highlights for the year 2005
2007
Thyronamines—Past, Present, and Future
2011
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue
2013
State-of-the-science of endocrine disrupting chemicals, 2012
2012
Mechanisms of Plaque Formation and Rupture
2014 Standout
Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance
2007
Aryl−Aryl Bond Formation by Transition-Metal-Catalyzed Direct Arylation
2007 Standout
Force Field Optimization Guided by Small Molecule Crystal Lattice Data Enables Consistent Sub-Angstrom Protein–Ligand Docking
2021 StandoutNobel
Transition-Metal-Catalyzed C−S, C−Se, and C−Te Bond Formation via Cross-Coupling and Atom-Economic Addition Reactions
2011 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
Benzofuran synthesis via copper-mediated oxidative annulation of phenols and unactivated internal alkynes
2013
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
2004
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
DITPA (3,5-Diiodothyropropionic Acid), a Thyroid Hormone Analog to Treat Heart Failure
2009
Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
2018 Standout
Rhodium(III)-Catalyzed C–H Olefination for the Synthesis of ortho-Alkenyl Phenols Using an Oxidizing Directing Group
2013
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
Molecular Docking Using the Molecular Lipophilicity Potential as Hydrophobic Descriptor: Impact on GOLD Docking Performance
2012
Synthesis of benzofurans via ruthenium-catalyzed redox-neutral C–H functionalization and reaction with alkynes under mild conditions
2014
The Metabolic Syndrome
2008 Standout
The Halogen Bond
2016 Standout
Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways
2013
Surgery for weight loss in adults
2014 Standout
Microwave-Assisted Copper-Catalyzed Preparation of Diaryl Chalcogenides
2006
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles
2011 Standout
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Silanol: A Traceless Directing Group for Pd-Catalyzed o-Alkenylation of Phenols
2011
Effects of the Thyromimetic Agent Diiodothyropropionic Acid on Body Weight, Body Mass Index, and Serum Lipoproteins: A Pilot Prospective, Randomized, Controlled Study
2010
In Vivo Activity of the Thyroid Hormone Receptor β- and α-Selective Agonists GC-24 and CO23 on Rat Liver, Heart, and Brain
2011
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
2012 Standout
Sulfur(VI) Fluoride Exchange (SuFEx)-Enabled High-Throughput Medicinal Chemistry
2020 StandoutNobel
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Proton-Coupled Electron Transfer
2012 Standout
An efficient aqueous microwave-assisted Suzuki–Miyaura cross-coupling reaction in the thiazole series
2009
One pot rhodium catalyzed, base and solvent-free synthesis of 2-(bromomethyl)furan derivatives and synthesis of Hashmi phenol through platinum catalyzed cascade cyclization
2013
Works of Johan Malm being referenced
Therapeutic Potential for Thyroid Hormone Receptor-β Selective Agonists for Treating Obesity, Hyperlipidemia and Diabetes
2007
Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor β subtype selective agonist KB-141
2008
Thyroid receptor ligands. Part 4: 4′-amido bioisosteric ligands selective for the thyroid hormone receptor beta
2005
Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta
2004
Recent Advances in the Development of Agonists Selective for β1-Type Thyroid Hormone Receptor
2006
Development of the Thyroid Hormone Receptor β-Subtype Agonist KB-141 : A Strategy for Body Weight Reduction and Lipid Lowering with Minimal Cardiac Side Effects
2006
Thyroid Hormone Antagonists: Potential Medical Applications and Structure Activity Relationships
2009
Selective thyroid hormone agonists: A strategy for treating metabolic syndrome
2005
Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability
2003
Thyroid Receptor Ligands. 6. A High Affinity “Direct Antagonist” Selective for the Thyroid Hormone Receptor
2006
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans
2007
Thyroid Receptor Ligands. 3. Design and Synthesis of 3,5-Dihalo-4-alkoxyphenylalkanoic Acids as Indirect Antagonists of the Thyroid Hormone Receptor
2005
An organoiron approach to thyroid hormone analogues
2005
Synthesis and Preliminary Characterization of a Novel Antiarrhythmic Compound (KB130015) with an Improved Toxicity Profile Compared with Amiodarone
2002
Thyroid receptor ligands. Part 5: Novel bicyclic agonist ligands selective for the thyroid hormone receptor β
2005
Thyroid Receptor Ligands. 1. Agonist Ligands Selective for the Thyroid Receptor β1
2003